31 Mar 2021
Assets26.34
Total Income25.06
Profit After Tax0.30
NET Worth7.47
Reserves and Surplus1.47
Total Borrowing9.59
At a glance
Updated 2026-08-24Medicamen Organics was incorporated in 1995 and operates in the PharmaceuticalsIncorporated1995Medicamen Organics Limited was segment. The shares listed at ₹137.85, a 305.44% move from the issue price. Medicamen Organics is a SME IPO with an issue size of ₹10.54 crore, proposed for listing on NSE SME. The offer opens on 21st Jun 2024 and closes on 25th Jun 2024. The issue structure includes a fresh issue of ₹9.96 crore. The current listing schedule points to 28th Jun 2024.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹10.54 Cr
Fresh issue₹9.96 Cr
Face value₹10
Price band₹32.00–₹34.00
Allotment26th Jun 2024
Listing28th Jun 2024
Listing performance
Full performance ↗Issue price₹34.00
Listing price₹137.85
Current price—
Listing gain305.44%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹70.00
GMP / upper price205.88%
Est. listing₹104.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens21st Jun 2024
Closes25th Jun 2024
Allotment26th Jun 2024
Refund27th Jun 2024
Demat27th Jun 2024
Listing28th Jun 2024
Subscription demand
Full bidding ↗Total993.56×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | ₹136,000 |
Company
SectorPharmaceuticalsIncorporated1995Medicamen Organics Limited was
Incorporated1995
Use of proceeds
| Object | Amount |
|---|---|
| Funding of expenses proposed to be incurred towards Product registration in the international markets | ₹3.00 Cr |
| Plant updation and increase in production capacity | ₹2.25 Cr |
| Funding working capital requirements of our Company | ₹4.00 Cr |
| General corporate purpose | ₹0.39 Cr |
Financials
Full financials ↗31 Mar 2022
Assets27.07
Total Income21.19
Profit After Tax0.09
NET Worth7.56
Reserves and Surplus1.56
Total Borrowing10.25
31 Mar 2023
Assets32.12
Total Income22.96
Profit After Tax0.96
NET Worth8.52
Reserves and Surplus2.52
Total Borrowing11.80
31 Mar 2024
Assets38.58
Total Income25.29
Profit After Tax2.40
NET Worth15.18
Reserves and Surplus6.58
Total Borrowing12.66
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt / Equity | 0.83% |
| RoNW | 15.83% |
| PAT Margin | 9.51% |
| Price to Book Value | 2.39 |
Valuation & shareholding
Pre-IPO EPS1.11
Post-IPO EPS2.21
Pre-IPO P/E30.53
Post-IPO P/E15.41
Promoter holding pre81.21%
Promoter holding post59.69%
Market cap₹39.78 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Issue Management fees including Merchant Banking fees, Underwriting fees and payment to other intermediaries such as Legal Counsel, Registrars and other out of pocket expenses | ₹0.78 Cr |
| Advertising and Marketing Expenses | ₹0.01 Cr |
| Fees payable to the stock exchange(s) | ₹0.05 Cr |
| 4 Printing & Stationery, Distribution, Postage, etc | ₹0.01 Cr |
| Brokerage and Selling Commission | ₹0.01 Cr |
| Other Expenses (Banker’s to the Issue, Auditor’s Fees etc.) | ₹0.03 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- GYR Capital Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.